Healthcare provider profile · identity verified

Daniel C Leman, APRN, CNP

Nurse Practitioner · PEORIA, IL · NPI 1285264523

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	402	160
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	315	48
Lisinopril	Lisinopril	273	104
Omeprazole	Omeprazole	244	96
Amlodipine Besylate	Amlodipine Besylate	187	65
Gabapentin	Gabapentin	182	62
Levothyroxine Sodium	Levothyroxine Sodium	176	64
Tramadol Hcl	Tramadol Hcl	172	38
Losartan Potassium	Losartan Potassium	153	50
Tamsulosin Hcl	Tamsulosin Hcl	145	58
Sertraline Hcl	Sertraline Hcl	144	53
Metformin Hcl	Metformin Hcl	143	43
Alprazolam	Alprazolam	141	28
Lorazepam	Lorazepam	134	36
Rosuvastatin Calcium	Rosuvastatin Calcium	131	56
Zolpidem Tartrate	Zolpidem Tartrate	115	27
Metoprolol Succinate	Metoprolol Succinate	113	46
Simvastatin	Simvastatin	111	32
Trazodone Hcl	Trazodone Hcl	108	38
Hydrochlorothiazide	Hydrochlorothiazide	107	47
Meloxicam	Meloxicam	107	37
Duloxetine Hcl	Duloxetine Hcl	102	24
Albuterol Sulfate Hfa	Albuterol Sulfate	97	37
Acetaminophen-Codeine	Acetaminophen With Codeine	93	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	90	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	88	25
Doxycycline Hyclate	Doxycycline Hyclate	85	64
Furosemide	Furosemide	80	32
Metformin Hcl Er	Metformin Hcl	79	32
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	76	30
Montelukast Sodium	Montelukast Sodium	75	21
Fluticasone Propionate	Fluticasone Propionate	72	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	26
Tizanidine Hcl	Tizanidine Hcl	66	13
Eliquis	Apixaban	65	24
Alendronate Sodium	Alendronate Sodium	64	26
Ezetimibe	Ezetimibe	63	17
Clonazepam	Clonazepam	61	12
Metoprolol Tartrate	Metoprolol Tartrate	59	25
Cephalexin	Cephalexin	57	34
Pravastatin Sodium	Pravastatin Sodium	50	18
Prednisone	Prednisone	50	39
Famotidine	Famotidine	48	12
Citalopram Hbr	Citalopram Hydrobromide	46	14
Venlafaxine Hcl Er	Venlafaxine Hcl	45	17
Warfarin Sodium	Warfarin Sodium	45	suppressed
Carvedilol	Carvedilol	44	20
Clopidogrel	Clopidogrel Bisulfate	43	17
Jardiance	Empagliflozin	43	13
Glipizide Er	Glipizide	40	15
Mounjaro	Tirzepatide	39	suppressed
Naproxen	Naproxen	39	15
Potassium Chloride	Potassium Chloride	39	13
Spironolactone	Spironolactone	39	16
Glipizide	Glipizide	38	13
Triamcinolone Acetonide	Triamcinolone Acetonide	38	23
Allopurinol	Allopurinol	37	17
Amitriptyline Hcl	Amitriptyline Hcl	37	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	12
Ondansetron Odt	Ondansetron	35	17
Fluoxetine Hcl	Fluoxetine Hcl	34	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Baclofen	Baclofen	33	12
Lovastatin	Lovastatin	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	11
Buspirone Hcl	Buspirone Hcl	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	12
Methylphenidate Hcl	Methylphenidate Hcl	31	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	31	suppressed
Betamethasone Valerate	Betamethasone Valerate	30	19
Escitalopram Oxalate	Escitalopram Oxalate	30	14
Hydroxyzine Hcl	Hydroxyzine Hcl	30	18
Pregabalin	Pregabalin	30	14
Bupropion Hcl Sr	Bupropion Hcl	28	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	27	12
Divalproex Sodium	Divalproex Sodium	27	suppressed
Fenofibrate	Fenofibrate	27	11
Incruse Ellipta	Umeclidinium Bromide	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Atenolol	Atenolol	26	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Glimepiride	Glimepiride	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	11
Temazepam	Temazepam	24	suppressed
Ozempic	Semaglutide	23	suppressed
Testosterone Cypionate	Testosterone Cypionate	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Estradiol	Estradiol	21	suppressed
Ketoconazole	Ketoconazole	21	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Diazepam	Diazepam	20	suppressed
Finasteride	Finasteride	20	suppressed
Invokana	Canagliflozin	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Bupropion Xl	Bupropion Hcl	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Indomethacin	Indomethacin	17	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	16	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	suppressed
Fluconazole	Fluconazole	16	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Nystatin	Nystatin	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Risperidone	Risperidone	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Clozapine	Clozapine	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Linzess	Linaclotide	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Ramipril	Ramipril	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error